Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines-Reference-Cited by-同舟云学术

Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines

Published:2023-06-09 Issue: Volume: Page:
ISSN:1867-1306
Container-title:Probiotics and Antimicrobial Proteins
language:en
Short-container-title:Probiotics & Antimicro. Prot.

Author:

Kerdkumthong Kankamol,Chanket Wannarat,Runsaeng Phanthipha,Nanarong Sutthipong,Songsurin Kawinnath,Tantimetta Phonprapavee,Angsuthanasombat Chanan,Aroonkesorn Aratee,Obchoei Sumalee

Funder

Prince of Songkla University-Ph.D. Scholarship

Thesis Research Grant from the Graduate School of Prince of Songkla University

The National Science, Research and Innovation Fund (NSRF) and Prince of Songkla University

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Molecular Medicine,Microbiology

Link

https://link.springer.com/content/pdf/10.1007/s12602-023-10096-0.pdf

Reference77 articles.

1. Macias RIR (2014) Cholangiocarcinoma: biology, clinical management, and pharmacological perspectives. ISRN Hepatol 2014:828074. https://doi.org/10.1155/2014/828074